These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 38397003)

  • 1. The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans.
    Mormone E; Cisternino A; Capone L; Caradonna E; Sbarbati A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome.
    Wen C; Xie L; Hu C
    J Cell Mol Med; 2022 Feb; 26(3):624-635. PubMed ID: 34953040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
    Kuo HC
    Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave.
    Lin CC; Huang YC; Lee WC; Chuang YC
    Int Neurourol J; 2020 Sep; 24(3):211-221. PubMed ID: 33017892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome.
    Dayem AA; Song K; Lee S; Kim A; Cho SG
    BMB Rep; 2022 May; 55(5):205-212. PubMed ID: 35410640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
    Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
    Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broaden Horizons: The Advancement of Interstitial Cystitis/Bladder Pain Syndrome.
    Li J; Yi X; Ai J
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-9-enriched mesenchymal stem cells derived exosomes prevent cystitis-induced bladder pain via suppressing TLR4/NLRP3 pathway in interstitial cystitis mice.
    Cui X; Bi X; Zhang X; Zhang Z; Yan Q; Wang Y; Huang X; Wu X; Jing X; Wang H
    Immun Inflamm Dis; 2024 Feb; 12(2):e1140. PubMed ID: 38415918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan.
    Yu WR; Kuo HC
    Low Urin Tract Symptoms; 2024 Jan; 16(1):e12508. PubMed ID: 37987028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives.
    Dayem AA; Kim K; Lee SB; Kim A; Cho SG
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32178321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
    Lee CL; Jiang YH; Kuo HC
    BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.
    Kim A; Shin DM; Choo MS
    Curr Urol Rep; 2016 Jan; 17(1):1. PubMed ID: 26686192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study.
    Charrua A; Pinto R; Taylor A; Canelas A; Ribeiro-da-Silva A; Cruz CD; Birder LA; Cruz F
    Neurourol Urodyn; 2015 Jun; 34(5):489-96. PubMed ID: 24375689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
    Logadottir Y; Hallsberg L; Fall M; Peeker R; Delbro D
    Scand J Urol; 2013 Feb; 47(1):52-6. PubMed ID: 22775390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review.
    Trama F; Illiano E; Marchesi A; Brancorsini S; Crocetto F; Pandolfo SD; Zucchi A; Costantini E
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome.
    Hu JC; Tzeng HT; Lee WC; Li JR; Chuang YC
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndrome.
    Ryu CM; Yu HY; Lee HY; Shin JH; Lee S; Ju H; Paulson B; Lee S; Kim S; Lim J; Heo J; Hong KS; Chung HM; Kim JK; Shin DM; Choo MS
    Theranostics; 2018; 8(20):5610-5624. PubMed ID: 30555567
    [No Abstract]   [Full Text] [Related]  

  • 19. Early three-month report of amniotic bladder therapy in patients with interstitial cystitis/bladder pain syndrome.
    Madan R; Radoiu C; Liaw A; Lucas S; Hamada A; Dhar N
    Int Urol Nephrol; 2023 Aug; 55(8):1937-1942. PubMed ID: 37273012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS).
    Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
    Expert Opin Emerg Drugs; 2015; 20(4):555-70. PubMed ID: 26535808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.